Dermaseptin-PP

General Information


DRACP ID  DRACP00997

Peptide Name   Dermaseptin-PP

Sequence  ALWKDMLKGIGKLAGKAALGAVKTLV

Sequence Length  26

UniProt ID  Not available

PubChem CID  Not available

Origin  Phyllomedusa palliata Skin Secretions

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
NCI-H157 Lung squamous cell carcinoma Carcinoma IC50=1.55 μM MTT assay 24h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=2.92 μM MTT assay 24h 1
PC-3 Prostate carcinoma Carcinoma IC50=4.15 μM MTT assay 24h 1
U-251MG Astrocytoma Carcinoma IC50=2.47 μM MTT assay 24h 1

Hemolytic Activity  Horse erythrocytes: Dermaseptin-PP exhibited only a moderate hemolytic effect (<20% at 16 μM with a calculated HC50 of 38.77 μM)

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00997

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C123H214N32O30S

Absent amino acids  CEFHNPQRSY

Common amino acids  AKL

Mass  309946

Pl  10.98

Basic residues  5

Acidic residues  1

Hydrophobic residues  14

Net charge  4

Boman Index  1605

Hydrophobicity  63.85

Aliphatic Index  131.54

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  220

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32582642

Title  Novel Frog Skin-Derived Peptide Dermaseptin-PP for Lung Cancer Treatment: In vitro/vivo Evaluation and Anti-tumor Mechanisms Study

Doi 10.3389/fchem.2020.00476

Year  2020

Patent

Patent ID CN115637282A

Patent Title  Research method of novel antibacterial peptide Dermaeptin-PP

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.